echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Drug price traceability platform or release of domestic drug companies in June

    Drug price traceability platform or release of domestic drug companies in June

    • Last Update: 2017-03-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: the price of cypress blue on March 20, 2017 ushered in the bottom PK ▍ the document was released in June, and it was learned from the people close to the relevant decision-making level that the information of drug ex factory price that has been brewing for one year can be traced, and it has been confirmed that the document will be officially issued in June this year According to the previous plan, the trans department cooperation led by the State Food and Drug Administration will establish a unified trans Department price information platform, do a good job in the interconnection with the centralized drug purchase platform (public resource trading platform) and the medical insurance payment audit platform, and strengthen the sharing with relevant tax data "At present, only a few provinces, such as Fujian and Jiangsu, have naked drug prices in China Once the traceability system is established, the national price information, bidding, medical insurance and tax network have a great impact on enterprises, which is an important means for the country to balance drug prices." Yesterday, some people in the pharmaceutical industry told cypress blue In August 2016, the code of conduct for market regulated drug prices in Jiangsu Province was implemented, which is also the first province in China to formulate such rules In the Jiangsu rules, the price form of drugs with market regulated price, the composition of drug price cost, and the principles followed by drug operators in accounting for drug prices are all clearly stated in the documents -- except for the pricing of narcotic drugs and class I psychotropic drugs by the government, the drug prices are subject to market regulation, and the drug operators shall, in accordance with the accounting standards for enterprises, general principles for enterprise finance, etc., in combination with the rules 》The main cost items of the drug price specified in the shall be accounted for in the cost of drug manufacturing, period expenses, profits, etc., and the price shall be independently determined by taking into account the market supply and demand situation, the market price of similar varieties and other factors The concept of cost control and price control, from the beginning, is the main goal of drug price traceability On October 6, 2016, Li Keqiang made it clear at the executive meeting of the State Council on April 6 that "medical reform has entered the deep-water area, we must take measures to overcome difficulties, and we must take" drug price "as a breakthrough." He stressed the need to accelerate the establishment of drug price traceability mechanism On the one hand, tracking management and ensuring the quality of drugs; on the other hand, promoting the disclosure of drug price information to make drug prices "transparent" Li Keqiang explicitly asked the relevant departments, "this problem can no longer be just 'research and research', we should speed up the promotion!" Finally, Premier Li Keqiang said that we should take the "drug price" as a breakthrough point, reduce the drug price, improve the performance-based wage system of medical institutions, so as to force the reform of public hospitals and the reform of drug distribution system and mechanism, and promote the in-depth development of medical and health system reform ▍ domestic pharmaceutical enterprises are under pressure, and this system will undoubtedly be the first to shock domestic enterprises On February 9, 2017, the general office of the State Council printed and issued several opinions on further reform and improvement of drug production, circulation and use policies, which once again explicitly included the drug price traceability mechanism "Improve the drug price monitoring system and promote the transparency of drug market price information The food and drug regulatory department takes the lead in initiating the establishment of a traceability mechanism for drug ex factory price information, establishing a unified cross departmental price information platform, doing a good job in interconnection with the drug centralized purchase platform (public resource trading platform) and the medical insurance payment audit platform, and strengthening the sharing with relevant tax data " The document emphasizes At the same time, the document emphasizes that "for pharmaceutical manufacturers that falsely report the prices of raw materials and the ex factory prices of pharmaceuticals, the price, food and drug supervision, tax and other departments shall investigate and deal with them seriously according to law, pay the taxes receivable and investigate the responsibilities of relevant responsible persons Strengthen the monitoring of the ex factory (port) price and the actual purchase and sale price of drugs with insufficient competition For drugs with abnormal price changes or excessive price differences with the same variety, timely research and analysis shall be carried out, and special investigation of cost and price shall be carried out when necessary " Previously, there was a view that as long as this code was associated with the upgrade of tax invoice system and drug price traceability system, the "one code to root" function of drug ex factory price traceability system was finally realized; however, due to the absence of production lines in China, the whole production cost of drugs in transnational pharmaceutical enterprises could not be fully collected at present, compared with domestic pharmaceutical enterprises, the pressure is huge Under the background of replacing business tax with value-added tax and two vote system, if the monitoring platform is connected with the drug price traceability system again, there is no obstacle for the drug price to be relatively open and transparent The production costs, profits and expenses of domestic production enterprises can be calculated and audited by the financial department, and how to release the pressure of marketing, expenses and profit control will become local The most pressing problem for pharmaceutical companies.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.